Advertisement
Trending - Altmetric
-
Ivermectin converts cold tumors hot and synergizes with immune checkpoint blockade for treatment of breast cancer
-
Treatment with trastuzumab deruxtecan in patients with HER2-positive breast cancer and brain metastases and/or leptomeningeal disease (ROSET-BM)
-
Durable responses in patients with HER2+ breast cancer and leptomeningeal metastases treated with trastuzumab deruxtecan
-
Targeting neddylation and sumoylation in chemoresistant triple negative breast cancer